Full text is available at the source.
Nitrogen-fused Heterocycles: Empowering Anticancer Drug Discovery
Nitrogen-based ring structures supporting anticancer drug development
AI simplified
Abstract
Over 85% of drugs with physiological activity contain heterocyclic structures or at least one heteroatom.
- Nitrogen-containing heterocycles are prevalent in medicinal chemistry and may play a crucial role in developing new anticancer agents.
- These compounds exhibit significant structural variety, allowing for potential customization in creating personalized cancer treatments.
- Computational techniques and studies on structure-activity relationships could enhance the rational design and optimization of new medications.
- The exploration of nitrogen-containing heterocycles represents a promising area of research in addressing the challenges posed by cancer.
AI simplified